2,2-difluoro-2-(2-pyridyl)ethanamine;hydrochloride, %, 250mg

9,9-Dimethyl-9H-9-silafluorene>98.0%(GC)1g

Benzyl methyl(2-(methylamino)ethyl)carbamate, 97%, 250mg

4-Amino-3-iodopyridine, 97.0%, 25g

2-(2,4-Dichloro-6-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95%, 1g

Ethyl 4-allylpiperidine-4-carboxylate hydrochloride, 97%, 250mg

(R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-acetylphenyl)propanoic acid, 98%, 1g

5-Bromo-6-fluoro-1H-indole-3-carboxylic acid, 98%, 1g

1-cyclohexanecarbonyl-3-methylpiperazine, 95.0%, 2g

Tris(3,5-di-tert-butylphenyl)phosphine, 98%, 5g

4-Ethynylaniline, 95.0%, 10g

7-TRIFLUOROMETHYL-IMIDAZO[1,2-A]PYRIDINE, 90.0%, 1g

Conjunto de polarización. El analizador se coloca en el ocular, el polarizador de 32 mm de diámetro se coloca en el portafiltros.